Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Dr Reddys Labs Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for DR REDDYS LABS INC, and what generic and branded alternatives to DR REDDYS LABS INC drugs are available?

DR REDDYS LABS INC has twenty-two approved drugs.

There are two tentative approvals on DR REDDYS LABS INC drugs.

Summary for Dr Reddys Labs Inc

US Patents:	0
Tradenames:	20
Ingredients:	20
NDAs:	22

Drugs and US Patents for Dr Reddys Labs Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dr Reddys Labs Inc	NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE	naproxen sodium; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	077381-001	Sep 27, 2006		OTC	No	No		Start Trial				Start Trial
Dr Reddys Labs Inc	SIMVASTATIN	simvastatin	TABLET;ORAL	077752-001	Dec 20, 2006	AB	RX	No	No		Start Trial				Start Trial
Dr Reddys Labs Inc	NEFAZODONE HYDROCHLORIDE	nefazodone hydrochloride	TABLET;ORAL	076309-003	Sep 16, 2003		DISCN	No	No		Start Trial				Start Trial
Dr Reddys Labs Inc	SUMATRIPTAN SUCCINATE	sumatriptan succinate	TABLET;ORAL	076847-002	Aug 10, 2009	AB	RX	No	No		Start Trial				Start Trial
Dr Reddys Labs Inc	ZIPRASIDONE HYDROCHLORIDE	ziprasidone hydrochloride	CAPSULE;ORAL	077565-002	Mar 2, 2012	AB	RX	No	No		Start Trial				Start Trial
Dr Reddys Labs Inc	RIVASTIGMINE TARTRATE	rivastigmine tartrate	CAPSULE;ORAL	077130-001	Oct 31, 2007	AB	RX	No	Yes		Start Trial				Start Trial
Dr Reddys Labs Inc	RIVASTIGMINE TARTRATE	rivastigmine tartrate	CAPSULE;ORAL	077130-004	Oct 31, 2007	AB	RX	No	Yes		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Medtronic

Colorcon

McKinsey

Dow

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.